Back to Assenagon Asset Management S.A. Assenagon Asset Management S.A.

BBIOBBIO
Showing 8 of 20 quarters

Position history for Assenagon Asset Management S.A.Assenagon Asset Management S.A.'s holdings in BRIDGEBIO PHARMA INC

Assenagon Asset Management S.A. holds 15,620 shares of BBIO (BRIDGEBIO PHARMA INC), worth $1.2M as of 2026-Q2. The position was decreased (-64.6% shares). BBIO represents 0.0% of Assenagon Asset Management S.A.'s portfolio.

Current Value

$1.2M

Current Shares

15,620

Total Value Change

+$548,926

Total Shares Change

-8,514

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
15,620
-64.6%
$1.2M0.0%$74.48
0
2026-Q1
Increased
44,092
+31.6%
$3.3M0.0%$74.26
34
2025-Q4
Decreased
33,513
-87.1%
$2.6M0.0%$76.49
0
2025-Q3
Decreased
258,904
-26.1%
$13.4M0.0%$51.94
0
2025-Q2
Decreased
350,411
-68.7%
$15.1M0.0%$43.18
0
2025-Q1
Increased
1.1M
+4544.6%
$38.8M0.1%$34.57
47
2024-Q4
Unchanged
24,134
0.0%
$662,2370.0%$27.44
0
2024-Q3
Decreased
24,134
-90.2%
$614,4520.0%$25.46
0

Other major holders of BBIO: VIKING GLOBAL INVESTORS LP, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used